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Many persistent organic pollutants (POPs) can 
be measured in human breast milk samples 
collected worldwide. Early exposure to POPs 
through breastfeeding significantly increases 
children’s body burden (Lanting et al. 1998; 
Patandin et al. 1997; Ribas-Fito et al. 2005) 
and is thought to be the primary determinant 
of children’s blood levels until at least 7 years 
of age (Barr et al. 2006). The impact of post-
natal intake of POPs on child development 
has been assessed in epidemiologic studies but 
results are mostly inconsistent (Jorissen 2007), 
possibly because of limitations in current 
methods used to assess exposure.
A handful of approaches were proposed 
to characterize children’s exposure to POPs 
via breastfeeding in epidemiologic studies. 
Huisman et al. (1995) used the concentra-
tion of polychlorinated biphenyls (PCBs) 
and dioxins in breast milk lipids as an esti-
mate of postnatal exposure. To account for 
duration of lactation, several epidemiologic 
studies multiplied breast milk concentration 
by the duration of breastfeeding (Grandjean 
et al. 2003; Jacobson and Jacobson 1996; 
Koopman-Esseboom et al. 1996; Rogan et al. 
1987). Pan et al. (2009) developed a simi-
lar exposure metric, but they distinguished 
exclusive from partial breastfeeding periods, 
and assumed that breast milk consumption 
when children were also given other supple-
ments is half that of children being exclusively 
breastfed. Direct measurement of POPs in 
children’s blood lipids was also used as a proxy 
of postnatal internal exposure (Boucher et al. 
2012; Grandjean et al. 2003; Jacobson and 
Jacobson 1996; Plusquellec et al. 2010; Saint-
Amour et al. 2006). None of these methods 
generates complete profiles of tissue or blood 
levels across development. Overall estimates 
may fail to detect associations with POPs that 
affect health during narrow time windows of 
exposure only (Hertz-Picciotto et al. 1996).
In a previous longitudinal birth cohort 
study, we estimated children’s blood POP pro-
file over the first year of life with a validated 
physiologically based pharmacokinetic (PBPK) 
model (Verner et al. 2010). Generating pro-
files of postnatal blood PCB-153 levels allowed 
us to assess exposure during different windows, 
an approach that led us to identify a postnatal 
interval of susceptibility to neurotoxic insults. 
The PBPK model was, however, quite   complex 
and did not allow the incorporation of cer-
tain individual variables such as gestational 
age, weight gain during pregnancy, and weight 
loss after delivery, all of which may modulate 
children’s exposure. Furthermore, this model 
required information on mothers’ and chil-
dren’s height at different times, which may not 
be systematically documented in epidemiologic 
studies. Finally, the model was validated only 
for simulations based on maternal blood levels 
and only until 6 months of age.
To overcome these limitations and ease 
the use of toxicokinetic modeling in epidemio-
logic studies, we developed a simplified model 
to simulate blood POP levels across childhood 
and validated it to 45 months of age using 
blood levels of children enrolled in two longi-
tudinal birth cohorts. We also assessed model 
validity for simulations based on levels in dif-
ferent samples: maternal blood, cord blood, 
and breast milk. We confined our analyses to 
four PCB congeners [International Union of 
Pure and Applied Chemistry (IUPAC) no. 
118, 153, 170, and 180], 1,1-dichloro-2,2-
bis(p-chlorophenyl)ethylene (p,p´-DDE), 
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Ba c k g r o u n d: Despite experimental evidence that lactational exposure to persistent organic 
  pollutants (POPs) can impact health, results from epidemiologic studies are inconclusive. 
Inconsistency across studies may reflect the inability of current methods to estimate children’s blood 
levels during specific periods of susceptibility.
oBjectives: We developed a toxicokinetic model to simulate blood POP levels in children from 
two longitudinal birth cohorts and aimed to validate it against blood levels measured at 6, 16, and 
45 months of age.
Me t h o d s : The model consisted of a maternal and a child lipid compartment connected through 
placental diffusion and breastfeeding. Simulations were carried out based on individual physiologic 
parameters; duration of breastfeeding; and levels of POPs measured in maternal blood at delivery, 
cord blood, or breast milk. Model validity was assessed through regression analyses of simulated 
against measured blood levels.
re s u l t s: Simulated levels explained between 10% and 83% of measured blood levels depending 
on the cohort, the compound, the sample used to simulate children’s blood levels, and child’s age 
when blood levels were measured. Model accuracy was highest for estimated blood POP levels at 
6 months based on maternal or cord blood levels. However, loss in model precision between the 6th 
and the 45th month was small for most compounds.
co n c l u s i o n s: Our validated toxicokinetic model can be used to estimate children’s blood POP 
  levels in early to mid-childhood. Estimates can be used in epidemiologic studies to evaluate the 
impact of exposure during hypothesized postnatal periods of susceptibility on health.
key w o r d s : children’s health, lactational exposures, longitudinal birth studies, persistent organic 
pollutants, toxicokinetic modeling. Environ Health Perspect 121:131–137 (2013).  http://dx.doi.
org/10.1289/ehp.1205552 [Online 17 October 2012]Verner et al. 
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1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane 
(p,p´-DDT) and hexachlorobenzene (HCB).
Methods
Conceptual representation. We developed this 
model based on the assumption that POPs 
distribute almost exclusively in lipids (Emond 
et al. 2005; Haddad et al. 2000). Therefore, 
we represented both the mother and child as 
lipid compartments (including blood lipids) 
connected through placental diffusion and 
excretion/intake of breast milk (Figure 1). 
The mother was exposed to POPs through 
ingestion of contaminated food. The child 
was exposed prenatally through placental dif-
fusion and postnatally through consumption 
of breast milk.
Parameterization. The complete set of 
parameters and equations is available in the 
model code provided in Supplemental Material 
(http://dx.doi.org/10.1289/ehp.1205552). 
Briefly, the kinetics of POPs are described as 
follows:
Absorption •	 . POPs in the gastrointestinal 
tract of both mothers and children were 
assumed to be fully absorbed as sug-
gested by results from experimental studies 
(McLachlan 1993).
Distribution •	 . Following absorption, POPs 
were assumed to distribute homogeneously 
in body lipids. During pregnancy, POPs 
were allowed to partition equally in maternal 
and fetal lipids. Mothers’ and children’s lipid 
volumes were scaled to individual-specific 
age and body weight according to data from 
Fomon et al. (1982) and the International 
Commission on Radiological Protection 
(ICRP 2002). The percentage of lipids in fetal 
tissues across pregnancy was set to values at 
birth—15% for males and 14% for females. 
Gain in body fat mass during pregnancy was 
calculated as the difference between weight 
gain and increase in lean tissues (fetus, uterus, 
placenta, amniotic fluid, blood, breasts, and 
extracellular and extravascular fluid). Fetal 
growth was based on a general growth curve 
(ICRP 2002) and individual birth weight, 
whereas increase in other lean tissues was the 
same for all women (increase of 5.8 kg at 
the end of pregnancy) (ICRP 2002). After 
delivery, the difference between weight and 
prepregnancy weight was considered to be 
strictly attributable to adipose tissue. This 
assumption was based on a study report-
ing that lean tissue gain during pregnancy is 
  rapidly lost after delivery (Butte et al. 2003). 
The additional adipose tissue during and after 
pregnancy was assumed to be composed of 
75% lipids (Baker 1969).
Metabolism and excretion •	 . Elimination 
due to biotransformation and fecal excre-
tion was set as an output from mother and 
children compartments with rates based on 
half-lives derived from cross-sectional data 
[PCB-118: 9.3 years; PCB-138: 10.8 years; 
PCB-153: 14.4 years; PCB-170: 15.5 years; 
PCB-180: 11.5 years (Ritter et al. 2011); 
p,p´-DDT: ~ 5 years (Smith 1999)] and lon-
gitudinal data [p,p´-DDE: 13 years (Wolff 
et al. 2000); HCB: 6 years (To-Figueras 
et al. 2000)]. Elimination rates (Kel) were 
calculated as follows:
  Kel = ln(2)/half-life.  [1]
Excretion of POPs in breast milk lipids was 
driven by children’s breast milk consump-
tion and breast milk lipid content. Milk con-
sumption during exclusive breastfeeding was 
described based on data from Salmenpera et al. 
(1985), expressed on the basis of children’s body 
weight and age by Arcus-Arth et al. (2005):
Hourly milk intake (L/kg body weight)  
  = –0.0024 × Age (years) + 0.0063.  [2]
From 12 until 24 months of age, we described 
breast milk consumption based on partial 
breastfeeding data published by Kent et al. 
(1999):
Hourly milk intake (L)  
  = –0.0086   × Age (years) + 0.0188.  [3]
We described breast milk lipids based on con-
centrations published by Bitman et al. (1983) 
and Arcus-Arth et al. (2005):
Fraction of lipids in breast milk (kg/L) 
  = 0.0034 × ln(Age [years]) + 0.0414.  [4]
Model inputs. To generate postnatal expo-
sure profiles, the model requires the inclusion 
of certain variables that are relevant to POP 
toxicokinetics: age of mother at delivery, 
prepregnancy body weight, child’s birth weight, 
child’s weight at one or more postnatal times 
(along with the time of measurement), duration 
of exclusive breastfeeding, duration of partial 
breastfeeding (when the child is fed both breast 
milk and other food), child’s sex, levels of POPs 
in maternal blood, cord blood or breast milk 
lipids (with the time of sampling), and half-
life of the POP to be modeled. In addition to 
these essential variables, the model can incorpo-
rate data on: weight gain during pregnancy and 
weight changes after delivery, gestational age at 
birth, and percentage of food intake attributable 
to breast milk during partial breastfeeding.
Inuit birth cohort. Pregnant Inuit women 
from Northern Quebec (Canada) were 
invited to participate in this longitudinal 
birth cohort shortly after their first prenatal 
visit (Muckle et al. 2001). Maternal and cord 
blood samples were collected at the time of 
delivery. Approximately 1 month after deliv-
ery, a sample of breast milk was obtained from 
mothers. Children’s blood was drawn around 
6 months (range, 1–14 months) after birth. A 
large array of organochlorines including pesti-
cides and PCBs was analyzed in these samples, 
as described by Muckle et al. (2001). In this 
cohort, information on breastfeeding was col-
lected 6 and 11 months after delivery. Only 
mother–child dyads with POP levels above 
the limit of detection and available data on 
duration of exclusive and partial breastfeed-
ing were included in the validation analyses. 
Missing maternal and child values for other 
variables were replaced by the variable’s mean 
value. A total of 160 children were included 
in the analyses. Detailed informed consent 
was provided by each participating mother. 
The research procedures were approved by the 
human subjects committees of Laval University 
and Wayne State University.
Slovak birth cohort. Women from the 
regions of Michalovce and Svidnik/Stropkov 
in Slovakia were invited to enroll in this lon-
gitudinal birth cohort at the time of delivery 
(Hertz-Picciotto et al. 2003). Maternal and 
cord blood samples were collected at the 
time of delivery. Blood samples were drawn 
from children at 6 months (range, 5.5–11.7), 
16 months (range, 11.8–22.0), and 45 months 
of age (range, 33.0–69.1). Mothers enrolled in 
this study were asked about their breastfeeding 
practices 6 months and 16 months after deliv-
ery. Available data on the duration of exclusive 
and partial breastfeeding and PCB levels above 
the limit of detection were the only inclusion 
criteria for validation analyses. A total of 795 
children were included in these analyses. This 
study was approved by Institutional Review 
Boards of the University of California, Davis 
(USA) and the Slovak Medical University in 
Bratislava, Slovakia. Written informed con-
sent was provided by all participants, and con-
sent was given by the parents for infants to 
  participate in the study.
Validation. We validated the model follow-
ing the steps presented in Figure 2. For both 
cohorts, individual-specific variables on age at 
delivery, prepregnancy weight, child weight, 
duration of exclusive and partial breastfeeding, 
and child sex were incorporated in the toxico-
kinetic model. Average values were used for 
weight gain during pregnancy (14.5 kg; Butte 
et al. 2003) and weight changes postpartum 
(2 kg above prepregnancy weight 0.5 year after 
delivery; Butte et al. 2003) because individual 
data were not collected in these cohorts. In 
addition, we assumed that maternal weight 
Figure 1. Conceptual representation of the toxico­
kinetic model.
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returned to prepregnancy weight by the end of 
the first year, and that breast milk consump-
tion during periods of partial breastfeeding was 
50% of the amount consumed by exclusively 
breastfed children at the same age.
We first estimated maternal lifetime daily 
POP oral intake based on levels measured in 
maternal blood at delivery, cord blood, or 
breast milk. We subsequently performed simu-
lations of children’s POP levels for each of the 
available samples (maternal blood, cord blood, 
and/or breast milk) and compared simulated 
with measured POP levels by linear regression 
to determine how much of the variability in 
measured blood levels could be explained by 
the toxicokinetic model based on the coef-
ficient of determination (R2). To avoid bias 
related to heteroskedasticity, measured and 
simulated levels were log-  transformed before 
regression analyses.
Global sensitivity analysis. To quan-
tify the impact of the various model inputs 
on simulated children’s blood POP levels, we 
ran a sensitivity analysis where model input 
values were iteratively sampled from specified 
ranges: prepregnancy body weight (51–114 kg; 
McDowell et al. 2005), weight gain dur-
ing pregnancy (7.6–32.0 kg; Sohlstrom and 
Forsum 1995), postpartum weight changes 
(–12 to 26 kg 1 year after delivery; Rossner 
1997), gestational age (22–42 weeks; Kramer 
et al. 2001), birth weight (0.34–4.9 kg; 
Kramer et al. 2001), weight at 6 months 
(6.4–9.8 kg; Kuczmarski et al. 2000), weight at 
1 year (8.4–12.8 kg; Kuczmarski et al. 2000), 
weight at 3 years (11.8–18 kg; Kuczmarski 
et al. 2000), duration of exclusive breastfeeding 
(0–12 months; arbitrary), duration of partial 
breastfeeding (0–45 months; arbitrary), frac-
tion of food intake attributable to breast milk 
during partial breastfeeding (0.1–0.9; arbitrary, 
single percentage used for the whole period of 
partial breastfeeding). 
In the model, certain parameters are likely 
to interact with each other (e.g., duration of 
partial breastfeeding and fraction of food intake 
attributable to breast milk), and the sensitivities 
reported should ideally account for these inter-
actions as thoroughly as possible. Commonly 
employed one-at-a-time local sensitivity analy-
ses (where only one parameter is varied while 
the others are kept constant) cannot account 
for these interactive effects. For this reason, we 
opted for an extended Fourier amplitude sen-
sitivity analysis (eFAST) (McNally et al. 2011). 
Although more computationally intensive, this 
global approach allows the quantitative cal-
culation of the relative contributions for a set 
of parameters over ranges of physiologically 
appropriate values—a clear advantage over local 
sensitivity analyses. Global sensitivity (total 
effects) obtained for each parameter at different 
time points (6, 16, and 45 months) was used 
to indicate its relative influence on the model 
output. We ran separate sensitivity analyses for 
PCB-153, a compound with a relatively long 
half-life, and p,p´-DDT, a compound with a 
relatively short half-life, in boys and in girls.
Exposure misclassification in epidemio-
logic studies. To illustrate that a commonly 
employed method to estimate postnatal expo-
sure can lead to exposure misclassification, we 
simulated profiles of blood PCB-153 levels in 
two Inuit children who had the same overall 
lactational exposure when estimated based 
only on the duration of breastfeeding and the 
concentration in breast milk (weeks breast-
feeding × ng/g milk lipids = ~ 4,700).
Model and software. Toxicokinetic 
modeling was performed using acslX (Aegis 
Technologies Group, Inc., Huntsville, AL, 
USA) and Microsoft Excel® 2007 (Microsoft, 
Redmond, WA, USA). Statistical analyses 
were conducted using SPSS for Windows sta-
tistical package version 20 (IBM, Chicago, IL, 
USA). The model code and automation script 
are provided in the Supplemental Material 
(http://dx.doi.org/10.1289/ehp.1205552).
Results
Inuit mothers who ever breastfed their child 
(89%) tended to do so exclusively for a longer 
period than their Slovak counterparts (100%). 
Moreover, the duration of exclusive breast-
feeding was more variable in the Inuit cohort 
(Table 1). Levels of PCBs and other organo-
chlorines in maternal and cord blood lipids 
were higher in the Slovak cohort, except for 
Figure 2. Steps undertaken to validate the toxicokinetic model.
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Table 1. Demographic characteristics [mean (5th–95th percentile)].
Characteristic Inuits (n = 160) Slovaks (n = 795)
Age at delivery (years) 25 (17–36) 26 (19–34)
Prepregnancy weight (kg) 71.2 (55.3–93.7) 60.2 (46.0–81.0)
Gestational age at birth (weeks) 39 (36–41) 40 (38–41)
Birth weight (kg) 3.5 (2.4–4.4) 3.4 (2.6–4.2)
Child weight at 6 months (kg) 9.6 (7.8–11.5) 7.9 (6.2–9.6)
Child weight at 16 months (kg) — 11.7 (9.0–14.3)
Child weight at 45 months (kg) — 17.0 (13.0–22.6)
Exclusive breastfeeding (days) 185 (6–370) 96 (30–183)
Total breastfeeding (days) 220 (7–391) 205 (30–487)Verner et al. 
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PCB-118, but the variability in levels, as indi-
cated by 5th–95th percentile ranges and their 
ratios, was relatively comparable (Table 2).
Accuracy of simulations for different com-
pounds. There was little variation in model 
accuracy across PCB congeners in both cohorts 
for a given sample type and age, although R2 
of measured against simulated levels were con-
sistently higher in the Inuit cohort than in 
the Slovak cohort (Table 3). In the Slovak 
cohort, the explained variability was somewhat 
lower for p,p´-DDE and HCB than for PCBs. 
Model accuracy was lower for p,p´-DDT than 
for other compounds in the Inuit cohort.
Sample used to simulate children’s blood 
levels. In the Slovak cohort, the model had 
similar predictiveness at each age regardless 
of the type of sample (cord blood or maternal 
blood at delivery) used to simulate children’s 
blood levels (Table 3). Predictiveness was also 
similar between cord blood and maternal blood 
for the Inuit cohort, but accuracy was lower for 
simulations based on milk samples (Table 3) 
and tended to overestimate children’s blood 
levels by an average of 60% (Figure 3).
Validity across development. Although the 
predictiveness of simulations for the Slovak 
cohort decreased as the age of children at 
blood sample measurement increased, the loss 
in accuracy was small for most compounds 
(Table 3, Figure 4). However, the decrease in 
R2 values was more pronounced for PCB-118, 
p,p´-DDT, and HCB, the compounds with 
the shortest half-lives.
Global sensitivity analysis. The influence of 
model inputs on children’s blood POP   levels 
was assessed using eFAST global sensitivity 
analysis. The global sensitivity (total effects) of 
the different parameters on POP levels varied 
depending on children’s age (Figure 5). Overall, 
breastfeeding-related parameters had a greater 
relative influence on simulated POP levels 
from 6 months up to 45 months. For example, 
nearly half the variability in simulated blood 
POP levels at 6 months of age could be attrib-
uted to the influence of duration of breast-
feeding, through first- or higher-order effects. 
As expected, weight gain during pregnancy 
had a greater influence on simulated levels at 
6 months than at 16 or 45 months, whereas 
postpartum weight changes became more 
influential over time. The relative sensitivity of 
estimates to changes in the child’s weight was 
lower than the sensitivity to changes in breast-
feeding and maternal weight parameters, except 
for birth weight, which had a relatively strong 
influence on simulated   levels at 6 months. 
Prepregnancy body weight and gestational age 
at birth had little influence on estimates.
Table 2. Median POP levels (ng/g lipids) in maternal blood at delivery, cord blood, and breast milk sam­
ples collected in the Inuit and Slovak studies. 
Compound
Maternal blood Cord blood Breast milk
Inuit (n = 156) Slovak (n = 754) Inuit (n = 81) Slovak (n = 752) Inuit (n = 130)
PCB-118 14 (5–46) 8 (1–45) 12 (4–57) 4 (1–38) 18 (6–71)
PCB-138 59 (21–167) 90 (32–360) 51 (16–200) 77 (21–345) 70 (22–262)
PCB-153 104 (32–336) 140 (53–553) 78 (22–319) 111 (34–457) 118 (41–412)
PCB-170 17 (6–65) 54 (20–209) 12 (4–51) 36 (8–154) 17 (4–75)
PCB-180 44 (14–155) 127 (49–523) 28 (9–122) 89 (25–376) 44 (15–167)
p,p´-DDE 281 (107–1,023) 432 (108–1,430) 276 (98–1,060) 409 (91–1,480) 384 (132–1,501)
p,p´-DDT 14 (3–38) 21 (7–82) 14 (5–40) 17 (4–65) 30 (8–95)
HCB 40 (15–122) 65 (5–302) 40 (17–148) 73 (5–329) 48 (15–133)
Values in parentheses represent the 5th and 95th percentiles.
Table 3. Regression analyses of blood POP levels measured at 6, 16, or 45 months of age against levels 
simulated from measured values in cord blood, maternal blood (at delivery), or breast milk (collected 
approximately 1 month postpartum).
Compound
Inuit cohort (months) Slovak cohort (months)
Cord 
blood
Maternal 
blood
Breast 
milk Cord blood Maternal blood
6 6 6 6 16 45 6 16 45
PCB-118
R2 0.74 0.73 0.63 0.52 0.46 0.33 0.55 0.41 0.33
n 60 126 112 205 726 404 215 728 390
PCB-138
R2 0.75 0.80 0.63 0.59 0.49 0.49 0.60 0.54 0.51
n 79 147 118 205 726 405 216 728 391
PCB-153
R2 0.74 0.81 0.65 0.57 0.51 0.50 0.59 0.53 0.51
N 79 150 118 205 726 405 216 728 391
PCB-170
R2 0.72 0.65 0.66 0.50 0.46 0.45 0.56 0.53 0.50
n 51 111 103 205 726 405 216 728 391
PCB-180
R2 0.75 0.77 0.63 0.59 0.51 0.50 0.60 0.54 0.51
n 78 143 117 205 726 405 216 728 391
p,p´-DDE
R2 0.76 0.83 0.62 0.40 0.48 0.39 0.49 0.44 0.39
n 81 156 118 205 726 405 216 728 391
p,p´-DDT
R2 0.52 0.47 0.49 0.57 0.44 0.31 0.58 0.45 0.30
n 48 103 102 205 726 406 216 717 391
HCB
R2 0.63 0.74 0.59 0.44 0.40 0.13 0.40 0.37 0.10
n 66 144 116 198 718 395 210 723 383
R2 values represent the fraction of variability in measured levels explained by the toxicokinetic model.
Figure 3. PCB­153 levels measured in children’s blood in the Inuit cohort plotted against blood PCB­153 levels simulated from cord blood, maternal blood at deliv­
ery, or breast milk concentrations. Axes are on a logarithmic scale.
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Exposure misclassification. There was a 
striking difference between the simulated 
profiles of PCB-153 levels of two Inuit chil-
dren with the same overall lactational expo-
sure calculated with the commonly employed 
approach of multiplying milk levels by the 
duration of breastfeeding (Figure 6). This was 
especially true at 3 months of age, when blood 
PCB-153 level in the child exposed to the 
highest breast milk level (639 ng/g lipids) was 
more than three times that of the other child 
(193 ng/g lipids).
Discussion
Adequate estimation of exposure to POPs 
through breastfeeding is critical for character-
izing associations between postnatal exposure 
and children’s health in epidemiologic stud-
ies. Here, we developed a simple toxicokinetic 
model that can simulate complete children’s 
blood POP profiles based on cord blood, 
maternal blood, or breast milk levels and 
assessed its accuracy by comparing simulated 
blood levels to levels measured in children 
from two longitudinal birth cohorts. Using 
this model, we have shown that estimations 
based solely on breast milk levels and dura-
tion of breastfeeding may lead to exposure 
misclassification (Figure 6).
Model predictiveness ranged from weak 
(R2 = 0.10) to high (R2 = 0.83) depending on 
the cohort, the compound, the sample used to 
simulate children’s blood levels, and the age of 
the child when blood was collected for mea-
surement. R2 values at 6 months of age were 
higher in the Inuit cohort than in the Slovak 
cohort, but R2 values cannot be compared 
across these studies because they may be influ-
enced by sample size. Predictiveness also varied 
depending on the modeled chemical, although 
the compounds for which the model showed 
poorer accuracy differed between the Inuit 
(p,p´-DDT) and Slovak (p,p´-DDE and HCB) 
studies. Possible causes for divergence in model 
accuracy include population-  specific physi-
ologic characteristics, variability in the percent-
age of food intake attributable to breast milk 
during partial breastfeeding, and differences in 
analytic precision between laboratories.
R2 values also varied depending on the 
sample used to simulate children’s exposure. 
Simulations based on maternal blood concen-
trations at delivery generally gave the best pre-
dictions, closely followed by those based on 
cord blood. When simulations were based on 
breast milk concentrations collected approxi-
mately 1 month postpartum, R2 values were 
slightly lower and children’s blood levels 
were overestimated, likely because of meth-
ods used to adjust for lipids. Whereas lipids 
in breast milk are almost exclusively neutral 
triacyglycerol (Jensen 1999) in which POPs 
partition, blood contains phospholipids that 
bind lipophilic compounds with lower affin-
ity (Poulin and Krishnan 1995). The usual 
method to adjust for blood lipids (Phillips 
et al. 1989) includes phospholipids and leads 
to a 40% overestimation of blood neutral lip-
ids when compared with breast milk. This 
compares well with our 60% overestimation 
of   children’s blood levels.
The model’s ability to estimate blood 
levels of children in the Slovak cohort 
decreased only slightly between 6 months 
and 45 months of age for most compounds, 
potentially because breastfeeding remains the 
main determinant of children’s blood levels 
throughout this period. In the same cohort 
of Inuits, Ayotte et al. (2003) could explain 
close to 50% of the variability in PCB-153 
blood concentration in a group of 87 children 
at 6 months based solely on the duration of 
exclusive breastfeeding. When both maternal 
blood concentration and duration of breast-
feeding were included in the regression model, 
this percentage increased to 66%. Similarly, 
Jacobson et al. (1989) could explain 60% of 
the variance in blood levels of 107 children 
at 4 years of age based on maternal milk PCB 
and weeks of breastfeeding, whereas children’s 
fish consumption had little relation to mea-
sured blood PCB levels. In 7-year-old Faroese 
children, the duration of breastfeeding was the 
primary predictor of blood POP levels, fol-
lowed by body mass index and intake through 
diet (Barr et al. 2006). These studies concur 
with our results suggesting that, even at high 
Figure 4. PCB­153 levels measured in children’s blood at 6, 16, and 45 months of age in the Slovak cohort plotted against blood PCB­153 levels simulated from cord 
blood concentrations. Axes are on a logarithmic scale.
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dietary exposures, breastfeeding is a primary 
predictor of children’s blood POP levels up to 
45 months of age.
Because epidemiologic questionnaires are 
invariably burdened with missing values and 
desired information is not systematically col-
lected (e.g., weight loss postpartum), use of 
this toxicokinetic tool requires dealing with 
missing model inputs. In global sensitivity 
analyses, we showed that breastfeeding param-
eters are highly influential, so availability of 
information on breastfeeding is paramount 
to achieve precise estimations with the PBPK 
model. The absence of nursing information 
should therefore be considered an exclusion 
criterion in studies on postnatal exposure to 
POPs. Weight gain during pregnancy and 
weight changes after delivery also proved to be 
influential. Variations in body weight, which 
indicate fluctuations in maternal body lipids, 
have been shown to modulate POP levels in 
blood lipids and subcutaneous adipose tissue 
(Chevrier et al. 2000), thereby affecting breast 
milk levels and, in turn, children’s exposure. 
Using average weight variation during and 
after pregnancy, as we did in this validation 
study, likely reduces model accuracy. On the 
other hand, child weight, gestational age at 
birth, and prepregnancy maternal weight dis-
played a relatively small influence on chil-
dren’s blood levels. Therefore, imputation 
of missing values can be performed without 
compromising model precision.
The model presented herein generates 
individualized exposure profiles from birth to 
45 months of age from which blood POP lev-
els can be determined for any period of inter-
est [Figure 6; see also Supplemental Material, 
Figure S1 (http://dx.doi.org/10.1289/
ehp.1205552)]. This is particularly useful when 
estimating the effects of POPs on systems that 
undergo specific developmental processes during 
constrained postnatal time frames, such as dur-
ing brain development, with cell proliferation, 
differentiation, migration, synapto  genesis, 
apoptosis, and myelination occurring in dif-
ferent regions during precise periods (Rice and 
Barone 2000). Our recent study in Inuits sup-
ported this contention, because prenatal and 
postnatal exposures to PCBs were associated 
with different behavioral end points (Verner 
et al. 2010).
Conclusions
The ability to detect associations between 
postnatal exposure to POPs and decrements 
in children’s health or development is tightly 
bound to our capacity to adequately estimate 
exposure during windows of susceptibility that 
are specific to the outcome of interest. Where 
such associations exist, the use of toxicokinetic 
modeling may facilitate their detection and 
characterization in epidemiologic studies.
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